Sign up to save your podcasts
Or
Share Weekly Stock Picks - 7/20/25
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Weekly Stock Picks - 7/20/25
This episode covers our 7/20 stock picks and their in-depth analysis.
We explore ASTS (AST SpaceMobile) as a high-risk, high-reward setup with technical breakout potential, noting its current price is above resistance and bullish momentum indicators. It's also highlighted as having potential for a double-bottom breakout.
Discover why LLY (Eli Lilly) is an oversold rebound candidate, supported by its robust pharma pipeline including Tirzepatide for obesity and Kisunla for Alzheimer’s. Its current price is below resistance, and RSI and KDJ indicate oversold conditions.
Plus, get insights into RTX (Raytheon Technologies), identified as an uptrend confirmation play with strong defense fundamentals. RTX showcases technical strength, robust revenue and net income, and significant defense contracts, emerging as a compelling investment opportunity in the aerospace sector.
We explore ASTS (AST SpaceMobile) as a high-risk, high-reward setup with technical breakout potential, noting its current price is above resistance and bullish momentum indicators. It's also highlighted as having potential for a double-bottom breakout.
Discover why LLY (Eli Lilly) is an oversold rebound candidate, supported by its robust pharma pipeline including Tirzepatide for obesity and Kisunla for Alzheimer’s. Its current price is below resistance, and RSI and KDJ indicate oversold conditions.
Plus, get insights into RTX (Raytheon Technologies), identified as an uptrend confirmation play with strong defense fundamentals. RTX showcases technical strength, robust revenue and net income, and significant defense contracts, emerging as a compelling investment opportunity in the aerospace sector.
View all episodes
By Greedy PotamusThis episode covers our 7/20 stock picks and their in-depth analysis.
We explore ASTS (AST SpaceMobile) as a high-risk, high-reward setup with technical breakout potential, noting its current price is above resistance and bullish momentum indicators. It's also highlighted as having potential for a double-bottom breakout.
Discover why LLY (Eli Lilly) is an oversold rebound candidate, supported by its robust pharma pipeline including Tirzepatide for obesity and Kisunla for Alzheimer’s. Its current price is below resistance, and RSI and KDJ indicate oversold conditions.
Plus, get insights into RTX (Raytheon Technologies), identified as an uptrend confirmation play with strong defense fundamentals. RTX showcases technical strength, robust revenue and net income, and significant defense contracts, emerging as a compelling investment opportunity in the aerospace sector.
We explore ASTS (AST SpaceMobile) as a high-risk, high-reward setup with technical breakout potential, noting its current price is above resistance and bullish momentum indicators. It's also highlighted as having potential for a double-bottom breakout.
Discover why LLY (Eli Lilly) is an oversold rebound candidate, supported by its robust pharma pipeline including Tirzepatide for obesity and Kisunla for Alzheimer’s. Its current price is below resistance, and RSI and KDJ indicate oversold conditions.
Plus, get insights into RTX (Raytheon Technologies), identified as an uptrend confirmation play with strong defense fundamentals. RTX showcases technical strength, robust revenue and net income, and significant defense contracts, emerging as a compelling investment opportunity in the aerospace sector.